iiCON and SME partner reach key stage in development of new Pneumoccal Disease Vaccine
The Infection Innovation Consortium: iiCON and partners have launched the first human challenge trial for a new vaccine for pneumococcal disease – marking a key milestone in a collaborative global project that is offering new hope in the fight against the disease.